<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomacromolecules</journal-id><journal-id journal-id-type="iso-abbrev">Biomacromolecules</journal-id><journal-id journal-id-type="publisher-id">bm</journal-id><journal-id journal-id-type="coden">bomaf6</journal-id><journal-title-group><journal-title>Biomacromolecules</journal-title></journal-title-group><issn pub-type="ppub">1525-7797</issn><issn pub-type="epub">1526-4602</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7173702</article-id><article-id pub-id-type="doi">10.1021/acs.biomac.0c00179</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Polymer-Stabilized Sialylated Nanoparticles: Synthesis,
Optimization, and Differential Binding to Influenza Hemagglutinins</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Richards</surname><given-names>Sarah-Jane</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Baker</surname><given-names>Alexander N.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Walker</surname><given-names>Marc</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath4"><name><surname>Gibson</surname><given-names>Matthew I.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department
of Chemistry, <institution>University of Warwick</institution>, Coventry CV4 7AL, <country>U.K.</country></aff><aff id="aff2"><label>&#x02021;</label>Warwick
Medical School, <institution>University of Warwick</institution>, Coventry CV4 7AL, <country>U.K.</country></aff><aff id="aff3"><label>&#x000a7;</label>Department
of Physics, <institution>University of Warwick</institution>, Coventry CV4 7AL, <country>U.K.</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>m.i.gibson@warwick.ac.uk</email>.</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>03</month><year>2020</year></pub-date><pub-date pub-type="ppub"><day>13</day><month>04</month><year>2020</year></pub-date><volume>21</volume><issue>4</issue><fpage>1604</fpage><lpage>1612</lpage><history><date date-type="received"><day>06</day><month>02</month><year>2020</year></date><date date-type="rev-recd"><day>19</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 American Chemical Society</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bm0c00179_0006" id="ab-tgr1"/></p><p>During
influenza infection, hemagglutinins (HAs) on the viral surface
bind to sialic acids on the host cell&#x02019;s surface. While all
HAs bind sialic acids, human influenza targets terminal &#x003b1;2,6
sialic acids and avian influenza targets &#x003b1;2,3 sialic acids.
For interspecies transmission (zoonosis), HA must mutate to adapt
to these differences. Here, multivalent gold nanoparticles bearing
either &#x003b1;2,6- or &#x003b1;2,3-sialyllactosamine have been developed
to interrogate a panel of HAs from pathogenic human, low pathogenic
avian, and other species&#x02019; influenza. This method exploits the
benefits of multivalent glycan presentation compared to monovalent
presentation to increase affinity and investigate how multivalency
affects selectivity. Using a library-orientated approach, parameters
including polymer coating and core diameter were optimized for maximal
binding and specificity were probed using galactosylated particles
and a panel of biophysical techniques [ultraviolet&#x02013;visible
spectroscopy, dynamic light scattering, and biolayer interferometry].
The optimized particles were then functionalized with sialyllactosamine
and their binding analyzed against a panel of HAs derived from pathogenic
influenza strains including low pathogenic avian strains. This showed
significant specificity crossover, which is not observed in monovalent
formats, with binding of avian HAs to human sialic acids and <italic>vice versa</italic> in agreement with alternate assay formats. These
results demonstrate that precise multivalent presentation is essential
to dissect the interactions of HAs and may aid the discovery of tools
for disease and zoonosis transmission.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>bm0c00179</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>bm0c00179</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Worldwide, annual epidemics
of seasonal influenza are estimated
to result in 3&#x02013;5 million cases of severe illness, and up to
650,000 deaths annually are associated with respiratory diseases from
seasonal influenza.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> While influenza A
and B viruses cause seasonal epidemics, only A types have been evidenced
to cause pandemics. Influenza A viruses are classified into subtypes
according to the combination of proteins on their surface; hemagglutinins
(HA) and neuraminidases (NA)&#x02014;for example, the H1N1 strain pandemic
in 2009.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> During infection, influenza virus
particles display trimeric HAs that bind to sialosides on the surface
of their host cells to facilitate internalization. While all influenza
strains bind sialosides, human strains preferentially bind to terminal
&#x003b1;2,6 sialic acids, whereas avian influenza viruses show preference
for &#x003b1;2,3 sialic acids.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref></sup> Zoonosis (interspecies
transmission) can occur due to mutations in the HA, enabling a switch
from &#x003b1;2,3 to &#x003b1;2,6. This allows avian influenza to infect
humans, and often occurs in porcine (pig) hosts, which present both
&#x003b1;2,3 to &#x003b1;2,6 sialosides in their respiratory tracts.<sup><xref ref-type="bibr" rid="ref5">5</xref>&#x02212;<xref ref-type="bibr" rid="ref7">7</xref></sup> Humans can be infected with avian, porcine, and other zoonotic influenza
viruses including avian influenza subtypes; H5N1, H7N9, and H9N2 and
swine flu virus subtypes; H1N1 (swine flu pandemic 2009), H1N2, and
H3N2.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> It has also emerged that <italic>N</italic>-glycolyl modifications (in addition to <italic>N</italic>-acetyl) play a significant role in species-dependent binding<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> and that influenza can bind phosphorylated, non-sialylated
glycans determined against an array of <italic>N</italic>-linked glycans
from human lungs,<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> suggesting that other
glycans are also involved, or potential targets during infection.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> Therefore, the study of HA interactions with
sialic acids is essential to increase our understanding of this global
pathogen and to help guide the discovery of new diagnostics and treatments.</p><p>The binding affinity of a HA toward an individual sialoside is
weak (<italic>K</italic><sub>d</sub> &#x02248; 2 mM),<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> but because of the multivalent presentation of both the
HA (&#x0223c;200&#x02013;1000 copies/virus) and the dense layer of sialic
acids on the cell surface,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> the affinity
is significantly increased by the cluster glycoside effect.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> Hence, <italic>in vivo</italic>, HAs engage
with cell&#x02013;surface sialic acids which are not presented as free
molecules in solution, but rather multivalent ensembles as in the
glycocalyx. Strategies to probe and dissect HA function should reproduce
this multivalent environment to be truly predictive. There are many
examples where multivalent materials, in particular polymers, have
been used to engage with carbohydrate binding proteins, with most
studies focusing on plant lectins, which are of limited biomedical
relevance.<sup><xref ref-type="bibr" rid="ref15">15</xref>&#x02212;<xref ref-type="bibr" rid="ref19">19</xref></sup></p><p>Whitesides and co-workers synthesized sialic acid containing
glycopolymeric
inhibitors of influenza virus X-31 <italic>via</italic> a poly(<italic>N</italic>-acrylyloxy succinimide) reactive scaffold. Using hemagglutination
and enzyme-linked immunosorbent assays, the inhibitory activity of
these polymers were found to be between 10<sup>3</sup> and 10<sup>6</sup> times greater than the free glycan.<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref21">21</xref></sup> However, the effect of the linkage was not examined. Miura and co-workers
synthesized 2,3- and 2,6-sialyllactose-functional glycopolymers that
were able to recognize two different influenza strains. They found
that 2,6-sialyllactose-functional glycopolymers inhibited hemagglutination
caused by H3N2 (A/Aichi/2/68) but not H1N1 (A/Puerto Rico/8/34); conversely,
2,3-sialyllactose-functional glycopolymers inhibited aggregation caused
by the H1N1 strain but not the H3N2.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> The
density and polymer length were found to affect the interaction with
the virus. Trivalent presentation of 2,3 sialic acids was sufficient
to give &#x0003e;400 fold increase in inhibitory activity against H3 influenzas.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> Godula and co-workers developed a microarray
platform for the evaluation of virus binding based on 2,6- and 2,3-sialyllactose
glycopolymers, which showed discrimination between different strains,
with H3N2 (A/Aichi/2/68) binding exclusively to 2,6-siallylactose
glycopolymers, whereas H1N1 (A/Puerto Rico/8/34) bound to both 2,3-
and 2,6-sialyllactose polymers.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> In addition
to the nature of the sialic acid, the 3-D presentation is a crucial
determinant with bivalent ligands showing wide affinity trends based
only on separation,<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> for example, H3N2
strains have evolved specificity related to the length of the sialosides
linker.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Furthermore, linear sialic acid
polymers were found to be more potent inhibitors than dendritic.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup></p><p>Gibson and co-workers have previously
developed multivalent gold/polymer
hybrids to dissect glycan binding interactions.<sup><xref ref-type="bibr" rid="ref28">28</xref>&#x02212;<xref ref-type="bibr" rid="ref31">31</xref></sup> Reversible addition fragmentation
chain transfer (RAFT) polymerization was used to produce telechelic
polymers that have a gold immobilization site at one end (masked thiol)
and a glycan installation site (an amine reactive pentafluorophenyl
group) at the other end. The polymer linker was found to be important,
ensuring a stable formulation and fast response readout.<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref30">30</xref></sup> The use of gold nanoparticle cores, exploiting their unique aggregation-induced
red-blue color shift, provides label-free readouts. This has been
used for the discrimination of human (H3N2) and avian (H5N1) influenza
using PEGylated gold particles presenting trivalent &#x003b1;2,6 sialic
acid ligands.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> Fairbanks and co-workers
investigated the interaction of HAs and whole viruses with gold nanoparticles
decorated with biantennary sialyloligosaccharides (&#x003b1;2,6 linked)
extracted from egg yolk. Selectivity was observed between two H1N1
strains, A/New Caledonia/20/1999 and A/Puerto Rico/8/34, which have
specificity toward &#x003b1;2,6 sialic acid and &#x003b1;2,3 sialic acid,
respectively.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> De Geest and co-workers
immobilized &#x003b1;2,6 sialic acid pendant glycopolymers on AuNPs
and observed an interaction with inactivated H1N1 (A/Puerto Rico/8/34)
viruses as determined by DLS; however, the selectivity compared with
other strains was not investigated.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> Furthermore,
Papp <italic>et al.</italic> showed the importance of gold core size
on the efficiency of virus inhibitions with 14 nm particles having
higher binding affinity than 2 nm particles.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> The gold particle size enables the generation of large signal responses
as well as multivalency; therefore, it is essential to optimize the
core size, linker, and glycan.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Lipid
bilayers and dendrimer scaffolds have also been employed to probe
or inhibit hemagglutinin binding.<sup><xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref38">38</xref></sup></p><p>Considering
the above, the aim of this work was to develop a multivalent
nanoparticle platform to dissect the binding trends of influenza HAs
toward multivalent sialic acid isomers. A library-oriented screen
of 27 nanoparticle formulations was used to identify the optimum size
and linker length, and then translated to enable 2,3- and 2,6-sialyllactosamine
attachment to multivalent gold nanoparticles. The binding affinities
of these particles were evaluated by colorimetric aggregation assays,
dynamic light scattering (DLS) and biolayer interferometry (BLI) to
ensure the whole binding landscape was probed. A panel of eight HAs,
including human and avian, were interrogated with the particles, and
it was demonstrated that the multivalent presentation enables significant
cross-binding between human and avian strains.</p></sec><sec id="sec2"><title>Experimental
Section</title><sec id="sec2.1"><title>Materials</title><p>All chemicals were used as supplied unless
otherwise stated. <italic>N</italic>-Hydroxyethyl acrylamide (HEA)
(97%), 4,4&#x02032;-azobis(4-cyanovaleric acid) (ACVA) (98%), mesitylene
(reagent grade), triethylamine (&#x0003e;99%), sodium citrate tribasic
dihydrate
(&#x0003e;99%), gold(III) chloride trihydrate (99.9%), and ammonium carbonate
(reagent grade) were all purchased from Sigma-Aldrich. <sc>d</sc>(+)-Galactosamine
hydrochloride (99%) was purchased from Acros Organics. 3&#x02032;-Sialyllactose
and 6&#x02032;-sialyllactose were purchased from Carbosynth. 2-(Dodecylthiocarbonothioylthio)-2-methylpropionic
acid pentafluorophenyl ester was synthesized as previously outlined
by Richards and Gibson.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> Soybean agglutinin
(SBA) and wheat germ agglutinin (WGA) were purchased from Vector Laboratories.
The following reagents were obtained through BEI resources, NIAID,
NIH: H1 HA protein from influenza virus, A/California/07/2009 (H1N1)pdm09,
recombinant from baculovirus, NR-44074, H2 HA protein from influenza
virus, A/Singapore/1/1957 (H2N2), recombinant from baculovirus, NR-2668,
H3 HA protein from influenza virus, A/Uruguay/716/2007 (H3N2), recombinant
from baculovirus, NR-15168, H4 HA protein from influenza virus, A/mallard/Alberta/455/2015
(H4N6), recombinant from baculovirus, NR-51128, H5 HA protein from
influenza virus, A/duck/Hunan/795/2002 (H5N1), recombinant from baculovirus,
NR-43739, H7 HA protein from influenza virus, A/Canada/rv444/2004
(H7N3), recombinant from baculovirus, NR-43740, H9 HA protein from
influenza virus, A/Hong Kong/33982/2009 (H9N2), recombinant from baculovirus,
NR-41792 and H10 HA protein with C-terminal histidine tag from influenza
virus, A/harbor seal/Germany/1/2014 (H10N7), recombinant from baculovirus,
NR-50172. Clear and black half are 96-well plates that were purchased
from Greiner Bio-One. Streptavidin (SA) biosensors were purchased
from ForteBio. Lectins and HAs were biotinylated using EZ-Link sulfo-NHS-LC-biotin
reagent from Thermo Fisher Scientific using standard procedure (20-fold
molar excess of biotin reagent, conjugation performed in phosphate-buffered
saline (PBS) buffer and isolated using Amicon Ultra-0.5 mL 3000 MWCO
centrifugal filters from Merck Millipore).</p></sec><sec id="sec2.2"><title>Physical and Analytical
Methods</title><p><sup>1</sup>H NMR spectra
were recorded on Bruker DPX-300 and DPX-400 spectrometers using deuterated
solvents purchased from Sigma-Aldrich. Chemical shifts are reported
relative to residual non-deuterated solvent. Size exclusion chromatography
(SEC) was carried out in dimethylformamide (DMF) and run on an Agilent
1260 Infinity II-MDS instrument equipped with differential refractive
index, dual wavelength UV detectors, viscometry and light scattering
detectors. The system was equipped with 2&#x000d7; PLgel mixed D columns
(300 &#x000d7; 7.5 mm) and a PLgel 5 &#x003bc;m guard column. The eluent
is DMF with 5 mM NH<sub>4</sub>BF<sub>4</sub> additive. Samples were
run at 1 mL&#x000b7;min<sup>&#x02013;1</sup> at 50 &#x000b0;C. Poly(methyl
methacrylate) (Agilent EasiVials) were used for calibration. Analyte
samples were filtered through a nylon filter with 0.22 &#x003bc;m pore
size before injection. Experimental molar mass (<italic>M</italic><sub>n</sub>,<sub>SEC</sub>) and dispersity (<italic>&#x00044;&#x00335;</italic>) values of synthesized polymers were determined by conventional
calibration using Agilent SEC/SEC software. The calibration range
is 500&#x02013;2,000,000 Da.</p></sec><sec id="sec2.3"><title>Lectin-Induced Aggregation Studies by Absorbance</title><p>A
stock solution of lectin was made (0.1 mg&#x000b7;mL<sup>&#x02013;1</sup> for SBA and 1 mg&#x000b7;mL<sup>&#x02013;1</sup> for WGA) in 10 mM HEPES
buffer with 0.15 M NaCl, 0.1 mM CaCl<sub>2</sub>, and 0.01 mM MnCl<sub>2</sub>. A serial dilution (25 &#x003bc;L) was made up in the same
buffer in a clear, flat bottom, half area 96-well microtiter plate.
GlycoAuNPs (250 &#x003bc;L) were added to each well and incubated at
room temperature for 30 min. After 30 min, an absorbance spectrum
was recorded from 450 to 700 nm with 10 nm intervals.</p></sec><sec id="sec2.4"><title>Biolayer Interferometry</title><p>BLI was carried out on ForteBio
Octet Red96 (ForteBio, USA). Assays were performed in black 96-well
half area plates. Assays were carried out at 30 &#x000b0;C and agitated
at 1000 rpm. SA biosensor tips (ForteBio, USA) were hydrated in milliQ
H<sub>2</sub>O water for at least 10 min prior to use. A stable baseline
was established in milliQ water for 1 min. The biosensors were functionalized
by loading with 10 &#x003bc;g/mL biotinylated lectin or HA in PBS for
5 min followed by a 1 min equilibration step in 10 mM HEPES with 0.15
M NaCl and 0.1 mM CaCl<sub>2</sub> and MnCl<sub>2</sub> to remove
any unbound protein and to establish a stable baseline. Following
protein immobilization, the binding association with galactosylated
and sialylated AuNPs was carried out in 10 mM HEPES with 0.15 M NaCl
and 0.1 mM CaCl<sub>2</sub> and MnCl<sub>2</sub> for 10 min followed
by dissociation in 10 mM HEPES with 0.15 M NaCl and 0.1 mM CaCl<sub>2</sub> and MnCl<sub>2</sub> for 10 min.</p></sec><sec id="sec2.5"><title>Synthetic Section</title><sec id="sec2.5.1"><title>Polymerization
of Hydroxyethyl Acrylamide Using PFP-DMP</title><p>HEA (0.5 g, 4.34
mmol), pentafluorophenyl 2-(dodecylthiocarbonothioylthio)-2-methylpropionic
acid (PFP-DMP) (0.092 g, 0.17 mmol), and ACVA (0.0097 g, 0.034 mmol)
were dissolved in 50:50 toluene/methanol (4 mL). Mesitylene (150 &#x003bc;L)
was added as an internal reference. An aliquot was taken for NMR analysis
in CDCl<sub>3</sub>. The solution was degassed under N<sub>2</sub> for 30 min. The reaction was stirred at 70 &#x000b0;C for 90 min. An
aliquot was taken for NMR analysis in MeOD. The reaction was rapidly
cooled in liquid nitrogen and precipitated into diethyl ether. The
polymer was reprecipitated into diethyl ether from methanol twice
to yield a yellow polymer product that was dried under vacuum. 96%
conversion by NMR, <italic>M</italic><sub>n</sub> (theoretical) =
3400 g&#x000b7;mol<sup>&#x02013;1</sup><italic>M</italic><sub>n</sub> (SEC) = 5800 g&#x000b7;mol<sup>&#x02013;1</sup><italic>M</italic><sub>n</sub>/<italic>M</italic><sub>w</sub> (SEC) = 1.16.</p></sec><sec id="sec2.5.2"><title>Gold Nanoparticle
Synthesis</title><p>Gold nanoparticles of differing
sizes were synthesized by the method developed by Bast&#x000fa;s et
al.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> A solution of 2.2 mM sodium citrate
in Milli-Q water (150 mL) was heated under reflux for 15 min under
vigorous stirring. After boiling had commenced, 1 mL of HAuCl<sub>4</sub> (25 mM) was injected. The color of the solution changed from
yellow to bluish gray and then to soft pink in 10 min. Immediately
after the synthesis of the Au seeds and in the same reaction vessel,
the reaction was cooled until the temperature of the solution reached
90 &#x000b0;C. Then, 1 mL of HAuCl<sub>4</sub> solution (25 mM) was injected.
After 30 min, the reaction was finished. This process was repeated
twice. After that, the sample was diluted by extracting 55 mL of the
sample and adding 53 mL of MilliQ water and 2 mL of 60 mM sodium citrate.
This solution was then used as a seed solution, and the process was
repeated a further 7 times. Generations 2, 5, and 8 were used for
this study (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>).</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Polymers Prepared in This Study</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><tbody><tr><td style="border:none;" align="center">polymer</td><td style="border:none;" align="center">[M]/[CTA]<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="center">conversion (%)<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="center"><italic>M</italic><sub>n(NMR)</sub> (g&#x000b7;mol<sup>&#x02013;1</sup>)<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="center"><italic>M</italic><sub>n(SEC)</sub> (g&#x000b7;mol<sup>&#x02013;1</sup>)<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="center"><italic>M</italic><sub>w</sub>/<italic>M</italic><sub>n</sub><xref rid="t1fn3" ref-type="table-fn">c</xref></td></tr><tr><td style="border:none;" align="center">Gal-PHEA<sub>10</sub></td><td style="border:none;" align="center">10</td><td style="border:none;" align="center">96</td><td style="border:none;" align="center">1600</td><td style="border:none;" align="center">2600</td><td style="border:none;" align="center">1.12</td></tr><tr><td style="border:none;" align="center">Gal-PHEA<sub>15</sub></td><td style="border:none;" align="center">15</td><td style="border:none;" align="center">99</td><td style="border:none;" align="center">2200</td><td style="border:none;" align="center">3300</td><td style="border:none;" align="center">1.16</td></tr><tr><td style="border:none;" align="center">Gal-PHEA<sub>20</sub></td><td style="border:none;" align="center">20</td><td style="border:none;" align="center">97</td><td style="border:none;" align="center">2800</td><td style="border:none;" align="center">4200</td><td style="border:none;" align="center">1.16</td></tr><tr><td style="border:none;" align="center">Gal-PHEA<sub>25</sub></td><td style="border:none;" align="center">25</td><td style="border:none;" align="center">98</td><td style="border:none;" align="center">3600</td><td style="border:none;" align="center">5800</td><td style="border:none;" align="center">1.16</td></tr><tr><td style="border:none;" align="center">Gal-PHEA<sub>30</sub></td><td style="border:none;" align="center">30</td><td style="border:none;" align="center">95</td><td style="border:none;" align="center">3800</td><td style="border:none;" align="center">7700</td><td style="border:none;" align="center">1.13</td></tr><tr><td style="border:none;" align="center">Gal-PHEA<sub>35</sub></td><td style="border:none;" align="center">35</td><td style="border:none;" align="center">97</td><td style="border:none;" align="center">4600</td><td style="border:none;" align="center">9500</td><td style="border:none;" align="center">1.14</td></tr><tr><td style="border:none;" align="center">Gal-PHEA<sub>40</sub></td><td style="border:none;" align="center">40</td><td style="border:none;" align="center">98</td><td style="border:none;" align="center">5000</td><td style="border:none;" align="center">8900</td><td style="border:none;" align="center">1.15</td></tr><tr><td style="border:none;" align="center">Gal-PHEA<sub>45</sub></td><td style="border:none;" align="center">45</td><td style="border:none;" align="center">94</td><td style="border:none;" align="center">5700</td><td style="border:none;" align="center">9200</td><td style="border:none;" align="center">1.15</td></tr><tr><td style="border:none;" align="center">Gal-PHEA<sub>50</sub></td><td style="border:none;" align="center">50</td><td style="border:none;" align="center">92</td><td style="border:none;" align="center">5800</td><td style="border:none;" align="center">10,300</td><td style="border:none;" align="center">1.15</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Feed ratio of monomer to chain-transfer
agent.</p></fn><fn id="t1fn2"><label>b</label><p>Determined by <sup>1</sup>H NMR.</p></fn><fn id="t1fn3"><label>c</label><p>Determined
by SEC in dimethylformamide
using poly(methyl methacrylate) standards. <italic>M</italic><sub>w</sub>, weight average molecular weight; <italic>M</italic><sub>n</sub>, number average molecular weight.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Nanoparticles Synthesized and Characterization</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="&#x000b1;"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center" char=".">&#x000a0;</th><th style="border:none;" align="center" char=".">&#x000a0;</th><th style="border:none;" align="center" char=".">&#x000a0;</th><th colspan="2" align="center" char=".">diameter
(nm)<hr/></th></tr><tr><th style="border:none;" align="center">particle</th><th style="border:none;" align="center" char=".">generation<xref rid="t2fn1" ref-type="table-fn">a</xref></th><th style="border:none;" align="center" char=".">&#x003bb;<sub>SPR</sub><xref rid="t2fn2" ref-type="table-fn">b</xref></th><th style="border:none;" align="center" char="."><italic>A</italic><sub>SPR</sub>/<italic>A</italic><sub>450</sub><xref rid="t2fn2" ref-type="table-fn">b</xref></th><th style="border:none;" align="center" char=".">UV&#x02013;vis<xref rid="t2fn3" ref-type="table-fn">c</xref></th><th style="border:none;" align="center" char="&#x000b1;">DLS<xref rid="t2fn4" ref-type="table-fn">d</xref></th></tr></thead><tbody><tr><td style="border:none;" align="left">Au<sub>30</sub></td><td style="border:none;" align="char" char=".">2</td><td style="border:none;" align="char" char=".">523</td><td style="border:none;" align="char" char=".">1.84</td><td style="border:none;" align="char" char=".">30</td><td style="border:none;" align="char" char="&#x000b1;">28.2&#x000a0;&#x000b1;&#x000a0;0.9</td></tr><tr><td style="border:none;" align="left">Au<sub>50</sub></td><td style="border:none;" align="char" char=".">5</td><td style="border:none;" align="char" char=".">531</td><td style="border:none;" align="char" char=".">2.00</td><td style="border:none;" align="char" char=".">50</td><td style="border:none;" align="char" char="&#x000b1;">48.8&#x000a0;&#x000b1;&#x000a0;0.4</td></tr><tr><td style="border:none;" align="left">Au<sub>70</sub></td><td style="border:none;" align="char" char=".">7</td><td style="border:none;" align="char" char=".">540</td><td style="border:none;" align="char" char=".">2.05</td><td style="border:none;" align="char" char=".">68</td><td style="border:none;" align="char" char="&#x000b1;">72.5&#x000a0;&#x000b1;&#x000a0;1.2</td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>a</label><p>Generation of nanoparticles used
from the seeding synthetic methodology (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biomac.0c00179/suppl_file/bm0c00179_si_001.pdf">Figure S1</ext-link>).</p></fn><fn id="t2fn2"><label>b</label><p>Maximum absorption
wavelength from
the surface plasmon resonance band of the particles and characteristic
ratio were used for diameter estimation.</p></fn><fn id="t2fn3"><label>c</label><p>Estimated using the method of Haiss <italic>et al.</italic>(<xref ref-type="bibr" rid="ref41">41</xref>) from UV&#x02013;vis.</p></fn><fn id="t2fn4"><label>d</label><p>Diameter from DLS &#x000b1; standard
error from three measurements.</p></fn></table-wrap-foot></table-wrap></sec></sec></sec><sec id="sec3"><title>Results and Discussion</title><p>To access multivalent glycosylated
gold nanoparticles, RAFT polymerization
was employed to synthesize telechelic poly(<italic>N</italic>-hydroxyethyl
acrylamide) (PHEA) ligands suitable for both nanoparticle immobilization,
and capture of glycans <italic>via</italic> a terminal pentafluoroethyl
ester (PFP),<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref31">31</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A). A range of degrees of polymerization (DP) was targeted
from DP10&#x02013;DP50 by varying the [M]/[CTA] ratio. The polymers
were characterized by SEC confirming narrow dispersity (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C and <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). 2-Deoxy-2-amino galactosamine was conjugated
to the &#x003c9;-terminal PFP, which also removes the dithiocarbonate
to reveal a thiol for subsequent AuNP conjugation. <sup>19</sup>F
NMR (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>D) was
used to confirm displacement of the PFP group. Note, GalNH<sub>2</sub> was chosen as the glycan to conduct initial screening, before progressing
to the sialic acid particles (vide infra).</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Synthetic strategy and
characterization of polymers and particles.
(A) Synthesis of galactose terminal PHEA; (B) step growth process
for the synthesis of gold nanoparticles; (C) SEC of Gal-PHEAs; (D) <sup>19</sup>F NMR showing displacement of the pentafluorophenyl unit;
(E) UV&#x02013;vis spectroscopy of uncoated AuNPs; (F) DLS of uncoated
AuNPs; (G&#x02013;I) TEM of uncoated AuNPs. Scale bar = 100 nm.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bm0c00179_0001" id="gr1" position="float"/></fig><p>To access a range of gold nanoparticles of defined
size, the kinetically
controlled seeded growth strategy based on the Turkevich/Frens method <italic>via</italic> the reduction of HAuCl<sub>4</sub> by sodium citrate
was used.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> This involved a growth process
leading to the enlargement of presynthesized 10 nm gold seeds <italic>via</italic> the surface-catalyzed reduction of Au<sup>3+</sup> by
sodium citrate (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B). This was characterized by UV&#x02013;vis spectroscopy (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>E), DLS (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>F), and transmission
electron microscopy (TEM) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>G&#x02013;I). The three different nanoparticle sizes
were coated with the nine different polymers to generate a diverse
library of 27 multivalent glyconanoparticles, this convergent strategy
maximized structural diversity. DLS measurements showed an increase
in hydrodynamic diameter, along with a red-shift in the SPR peak (&#x003bb;<sub>max</sub>), both consistent with polymer coating. X-ray photoelectron
spectroscopy (XPS) was used to confirm polymer coating on AuNPs by
increased N 1s (from amide) as well as C 1s signals (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biomac.0c00179/suppl_file/bm0c00179_si_001.pdf">Supporting Information</ext-link>, Tables S1 and S2, Figures S2&#x02013;S5).</p><p>To enable protein binding studies, it was essential to first screen
the library for colloidal stability in the buffer to prevent false
positives in aggregation screens. Both particle size and polymer length
impact this, and it is a crucial step in any binding assay. The galactose
functional particles were screened for aggregation stability by observing
the increase in Abs<sub>700</sub>. A NaCl gradient (0&#x02013;1 M)
as well as HEPES buffer were tested (full data set is in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biomac.0c00179/suppl_file/bm0c00179_si_001.pdf">Supporting Information</ext-link>, Figure S6). From this,
it was clear that for all particle sizes, ligands with a DP above
25 were essential to obtain colloidally stable particles, in line
with the previous reports.<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref42">42</xref></sup> From this screen, it
was decided to study protein binding using particles coated with polymers
DP25&#x02013;DP50 to avoid false positives due to buffer-induced aggregation.
To screen for binding, the model lectin, SBA was used to validate
the methods and to establish which particle structural requirements
gave the strongest outputs, <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Galactosylated particles and SBA binding. (A) Aggregation
of gold
particles leading to red-blue color shift due to SPR band coupling.
Change in Abs<sub>700</sub> using 500 nM SBA as a function of coating
and core size. Full binding curves from 500 to 0 nM are in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biomac.0c00179/suppl_file/bm0c00179_si_001.pdf">Supporting Information</ext-link>, Figure S7; (B) BLI schematic,
showing capture of SBA and subsequent binding to AuNPs to generate
signal. Total binding (&#x00394;<sub>max</sub>) as a function of coating
and core size. Full binding curves are in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biomac.0c00179/suppl_file/bm0c00179_si_001.pdf">Supporting Information</ext-link>, Figure S8.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bm0c00179_0002" id="gr2" position="float"/></fig><p><xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A shows
the outputs of this aggregation screen as a function of polymer ligand
length and nanoparticle size. Full dose-dependent curves are in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biomac.0c00179/suppl_file/bm0c00179_si_001.pdf">Supporting Information</ext-link> (Figure S6). For all polymer
lengths, the largest changes were seen for the shortest polymer chain
length (DP25) with a step-wise decrease as polymer length increases,
and the biggest (70 nm) particles gave the largest outputs. Although
the aggregation assay used above provides a convenient output of binding,
it cannot rule out the case where lectins bind but fail to agglutinate.
For example, the longer polymer linkers are likely able to bind to
SBA, but also provide a steric block against agglutination, highlighting
the need for tuning of these parameters. Therefore, a second assay
using BLI was developed.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> In short, biotinylated
SBA was immobilized onto SA functional BLI sensors (ForteBio) (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B) and the nanoparticles
exposed to this. As BLI is mass sensitive, individual glycans do not
give a strong signal, but when coupled in this nanoparticle format,
larger signals are obtained. In addition, cluster glycoside enhancement
is achieved and is a key benefit of this approach. The total BLI signal
as a function of particle parameters is shown in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>D. The shorter polymers at
all particle sizes gave the largest outputs; however, there was little
binding observed to the SBA when DP50 polymers were used. This suggests
that the lower density of longer polymers is reducing overall affinity
and multivalent enhancement. Brewer and co-workers,<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref45">45</xref></sup> and Godula and Bertozzi<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> observed valency-dependent
binding of SBA to GalNAc-functionalized mucins/mucin-like materials.
Furthermore, Gibson and co-workers have previously shown density-dependent
binding of SBA to heterogenous AuNPs.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> Larger particles gave more signal, but it should be noted that BLI
is a mass-weighted analysis method and hence only qualitative trends
can be compared for nanoparticle size.</p><p>Guided by the above data,
using galactose functional nanoparticles,
the primary aim of studying multivalent sialic acid particles could
be investigated on the optimized scaffold. 1-Deoxy, 1-amino, 2,3-
and 2,6-sialyllactose were synthesized by the single-step Kochetkov
amination method<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A, with the amination confirmed by mass spectrometry).
Using the same procedure as GalNH<sub>2</sub>, the sialyllactosamines
(SLs) were conjugated to DP25 PHEA and subsequently used to coat 70
nm AuNPs. This single polymer/particle combination was chosen based
on the above screening (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>), which ensured that particles that generate the largest
signals with consistent grafting densities were used.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Synthesis of sialylated
gold nanoparticles. (A) Amination of 2,3-
and 2,6- sialyllactoses using Kochetkov method; (B) reaction of DP25
PFP-PHEA with sialyllactoamines and subsequent immobilization of the
polymers onto 70 nm gold nanoparticles.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bm0c00179_0003" id="gr3" position="float"/></fig><p>These glycoparticles were first tested against WGA, a lectin known
to have some affinity to sialic acids.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Using UV&#x02013;vis to monitor aggregation, it appeared that both
2,3- and 2,6-sialyllactosamines had similar affinities toward WGA
(<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A), which
was not expected. However, parallel DLS investigations (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>B) showed 2,6-sialyllactosamine
to cluster faster and to give larger cluster sizes, which is consistent
with it having a stronger interaction than 2,3-sialyllactosamine.
BLI analysis against WGA immobilized on a surface showed greater specificity
for the 2,6-sialyllactosamine compared to 2,3-sialyllactosamine, which
is in line with the previous reports. This set of analyses shows that
the colorimetric changes of glyconanoparticles are useful for comparisons
of affinity, but more detailed methods (such as the BLI) are required,
especially if unknown/new interactions are being evaluated.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Interaction
of SL-functionalized particles: 2,3-SL-PHEA@AuNP (black
&#x025a0;), 2,6-SL-PHEA@AuNP (red &#x025cf;), and Gal-PHEA@AuNP (blue
&#x025b2;) with WGA by (A) UV&#x02013;vis; (B) DLS; and (C) BLI.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bm0c00179_0004" id="gr4" position="float"/></fig><p>The above data shows that DP25 PHEA ligands on
70 nm particles
give strong binding, and that the amidation/conjugation methodology
enables installation of sialic acid isomers with retention of their
biological binding specificities and affinities. The particles were
then taken forward into a screen against a panel of HAs. A single
nanoparticle/polymer length combination was used to ensure that grafting
density differences did not affect the observed outcomes, where glycan
density display is likely to play a significant role.</p><p>Influenza
A can be categorized by the different subtypes of the
proteins present of which there are at least 18 different HA subtypes
named H1 to H18.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> The panel of HAs used
were from the five strains with human hosts: H1 from A/California/07/2009
(H1N1)pdm09, H2 from A/Singapore/1/1957 (H2N2), H3 from A/Uruguay/716/2007
(H3N2), H7 from, A/Canada/rv444/2004 (H7N3), and H9 from A/Hong Kong/33982/2009
(H9N2); and two from avian hosts: H4 from A/mallard/Alberta/455/2015
(H4N6) and H5 from A/duck/Hunan/795/2002 (H5N1); and another zoonotic
strain, H10 from A/harbor seal/Germany/1/2014 (H10N7) (seal host),
and it enables the study of pathogenic processes without the need
for intact viral particles. HAs were immobilized onto the BLI sensors
using biotin/SA (as above). BLI has been widely used to evaluate hemagglutinin/neuraminidase
function using isolated proteins and the whole virus.<sup><xref ref-type="bibr" rid="ref49">49</xref>&#x02212;<xref ref-type="bibr" rid="ref51">51</xref></sup><xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A shows example
BLI curves of 2,6-sialyllactosamine nanoparticles against the HA panel
and <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B shows
BLI curves of 2,3-sialyllactosamine nanoparticles. There was a difference
in response in terms of total mass captured and the rate of binding,
reiterating the range of binding affinities shown by HAs from different
pathogenic strains (low pathogenic avian strains) when presented in
a multivalent format. To enable comparison, <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>C shows the maximal binding of the particles
to the HAs for both 2,3- and 2,6-sialyllactosamine-functionalized
AuNPs. A key feature here is that although many of the avian HAs are
characterized as being &#x003b1;2,3-selective based on previous studies
using monovalent compounds, there is clearly cross-affinity in most
cases using our multivalent system. This shows the importance of this
study, as it shows that glycan specificity can change when in multivalent
format because of the enhancement of weak interactions, as well as
stronger ones. H9 in particular showed significant binding to both
2,3-sialyllactosamine and 2,6-sialyllactosamine AuNPs, indicating
that it can bind to both human and avian sialic acids, which is consistent
with the virus being of avian origins infecting a human host. This
crossover in binding has also been observed by Godula and co-workers,<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> where significant binding of H1N1 (A/Puerto
Rico/8/34 which transmitted into humans) was noted toward both &#x003b1;2,6
and &#x003b1;2,3 sialylated polymer microarrays. In contrast, more discrete
binding was observed with H3N2 (A/Aichi/2/68) which bound only to
&#x003b1;2,6 but not to &#x003b1;2,3 sialylated polymer arrays (note that
the specific strains were not the same as used in this study). Furthermore,
McCauley and co-workers have investigated the mammalian transmissibility
of many avian and other zoonotic influenza strains including H7N9,<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> H9N2,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> and H10N8<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> by looking at the binding of sialylated polymers
to viruses. In particular, a panel of H9N2 viruses from different
origins were assessed for their binding to &#x003b1;2,6 and &#x003b1;2,3
sialylated polymer-functionalized BLI sensors.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> Wide-ranging binding variability was noted to different
H9N2 viruses, with the H9N2 (A/Hong Kong/33982/2009) virus (the same
H9 used in this study) showing greater binding toward &#x003b1;2,6 sialylated
polymers over &#x003b1;2,3 sialylated polymers, which is in agreement
with our results here, supporting the approach taken (dose-dependent
BLI binding curves for H1 from A/California/07/2009 (H1N1)pdm09, H7
from A/Canada/rv444/2004 (H7N3), and H9 from H9N2 (A/Hong Kong/33982/2009)
in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biomac.0c00179/suppl_file/bm0c00179_si_001.pdf">Supporting Information</ext-link>, Figures
S12&#x02013;S14). The H7N9 strain has been reported to retain its avian
affinity preference even with mutations to target human receptors,
which we also observed using this nanoparticle system.<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> To visualize these differences, <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>D plots the relative binding
preferences, defined as the maximal binding of 2,6-sialyllactosamine
nanoparticles, minus the maximal binding of 2,3-sialyllactosamine
to each hemagglutinin. As the same coating and same nanoparticle core
was used in each case, this enabled visualization of the differences
in total particle captured to the haemagglutinin. These results show
that our nanoparticle system generates sufficient signal amplification
to enable the evaluation of glycans for binding haemagglutinins and
to unravel the cross-affinity due to the multivalent presentation.
It is important to note that these results may be specific to the
sialyllactose ligands being employed here, which are readily available
compared to, for example, complex branched glycans. It does show that,
however, in multivalent format both the extent of binding and relative
binding between the isomers varies between the hemagglutinins and
may offer routes to multiplexed sensing and discrimination.</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Interaction
of SL-functionalized nanoparticles with a panel of
HAs using BLI. (A) 2,3-SL-PHEA@AuNP and (B) 2,6-SL-PHEA@AuNP BLI binding
curves to HA panel (H1 from A/California/07/2009 (H1N1)pdm09, H2 from
A/Singapore/1/1957 (H2N2), H3 from A/Uruguay/716/2007 (H3N2), H4 from
A/mallard/Alberta/455/2015 (H4N6), H5 from A/duck/Hunan/795/2002 (H5N1),
H7 from, A/Canada/rv444/2004 (H7N3), NR-43740, H9 from A/Hong Kong/33982/2009
(H9N2), and H10 from A/harbor seal/Germany/1/2014 (H10N7)); (C) comparison
of the maximal binding of 2,3-SL-PHEA@AuNP and 2,6-SL-PHEA@AuNP to
the HA panel; (D) difference (subtraction) between maximal binding
to 2,6-SL-PHEA@AuNP and 2,3-SL-PHEA@AuNP to visualize relative binding
preferences.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bm0c00179_0005" id="gr5" position="float"/></fig></sec><sec id="sec4"><title>Conclusions</title><p>Here, we have developed
a multivalent nanoparticle approach to
investigate the affinity of sialic acid isomers against a panel of
influenza A HAs to map their affinity. This allows for the probing
of specificity and affinity trends while benefitting from signal amplification
due to particle size. The multivalent nanoparticles were synthesized
using polymeric ligands bearing a glycan capture (pentafluorophenyl
ester) and a gold immobilization (thiol) termini. Initial screening
of a library of 27 nanoparticles, varying in ligand length and core
diameter, enabled identification of the optimum multivalent probe,
using a model lectin and complementary UV&#x02013;vis, DLS, and BLI
analysis. 2,3- and 2,6-sialyllactosamine were conjugated to these
particles <italic>via</italic> a Kochetkov amination step, which were
then interrogated for their binding against a panel of influenza A
HAs including three mammalian strains, four avian strains, and a zoonotic
influenza strain. As expected, 2,3-sialyllactosamine had strong affinity
toward avian strains and 2,6-sialyllactosamine against mammalian.
However, the analysis also revealed that in multivalent format, there
was significant crossover in affinities. All avian influenzas showed
affinity toward the multivalent 2,6-sialyllactosamine particles suggesting
the potential for crossover due to multivalency. It is important to
note that this study does not predict zoonosis potential, but rather
highlights that multivalent nanoparticle presentation affects the
affinity/selectivity trends compared to monovalent compounds. The
identification of off-specific binding profiles is crucial to help
develop nanomaterials for biosensing and monitoring of emerging infectious
diseases.</p></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting
Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.biomac.0c00179?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.biomac.0c00179</ext-link>.<list id="silist" list-type="simple"><list-item><p>Additional nanoparticle
characterization (XPS and DLS),
full UV&#x02013;visible spectroscopy curves for the lectin binding
assays, and underpinning BLI binding curves (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.biomac.0c00179/suppl_file/bm0c00179_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bm0c00179_si_001.pdf"><caption><p>bm0c00179_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="COI-statement" id="NOTES-d7e1107-autogenerated"><p>The authors
declare no
competing financial interest.</p></notes><notes notes-type="" id="notes2"><title>Notes</title><p>The research
data supporting this publication
can be found at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://wrap.warwick.ac.uk">http://wrap.warwick.ac.uk</uri>.</p></notes><ack><title>Acknowledgments</title><p>M.I.G. holds an
ERC starting grant (CRYOMAT 638661).
The Royal Society are also thanked for funding the cryo-microscopes
used in this study. BBSRC/Innovate are thanked for funding the Specialty
Glycans project BB/M02878X/1. The BBSRC-funded MIBTP program (BB/M01116X/1)
and Iceni Diagnostics ltd are thanked for a studentship for A.N.B.
The Warwick Polymer Research Technology Platform is acknowledged for
the SEC analysis. Laura Wilkins (UoW) is thanked for the TEM analysis.
The following reagents were obtained through BEI Resources, NIAID,
NIH: H1 HA protein from influenza virus, A/California/07/2009 (H1N1)pdm09,
recombinant from baculovirus, NR-44074, H2 HA protein from influenza
virus, A/Singapore/1/1957 (H2N2), recombinant from baculovirus, NR-2668,
H3 HA protein from influenza virus, A/Uruguay/716/2007 (H3N2), recombinant
from baculovirus, NR-15168, H4 HA protein from influenza virus, A/mallard/Alberta/455/2015
(H4N6), recombinant from baculovirus, NR-51128, H5 HA protein from
influenza virus, A/duck/Hunan/795/2002 (H5N1), recombinant from baculovirus,
NR-43739, H7 HA protein from influenza virus, A/Canada/rv444/2004
(H7N3), recombinant from baculovirus, NR-43740, H9 HA protein from
influenza virus, A/Hong Kong/33982/2009 (H9N2), recombinant from baculovirus,
NR-41792 and H10 HA protein with C-terminal histidine tag from influenza
virus, A/harbor seal/Germany/1/2014 (H10N7), recombinant from baculovirus,
NR-50172.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Iuliano</surname><given-names>A. D.</given-names></name>; <name><surname>Roguski</surname><given-names>K. M.</given-names></name>; <name><surname>Chang</surname><given-names>H. H.</given-names></name>; <name><surname>Muscatello</surname><given-names>D. J.</given-names></name>; <name><surname>Palekar</surname><given-names>R.</given-names></name>; <name><surname>Tempia</surname><given-names>S.</given-names></name>; <name><surname>Cohen</surname><given-names>C.</given-names></name>; <name><surname>Gran</surname><given-names>J. M.</given-names></name>; <name><surname>Schanzer</surname><given-names>D.</given-names></name>; <name><surname>Cowling</surname><given-names>B. J.</given-names></name>; <name><surname>Wu</surname><given-names>P.</given-names></name>; <name><surname>Kyncl</surname><given-names>J.</given-names></name>; <name><surname>Ang</surname><given-names>L. W.</given-names></name>; <name><surname>Park</surname><given-names>M.</given-names></name>; <name><surname>Redlberger-Fritz</surname><given-names>M.</given-names></name>; <name><surname>Yu</surname><given-names>H.</given-names></name>; <name><surname>Espenhain</surname><given-names>L.</given-names></name>; <name><surname>Krishnan</surname><given-names>A.</given-names></name>; <name><surname>Emukule</surname><given-names>G.</given-names></name>; <name><surname>van Asten</surname><given-names>L.</given-names></name>; <name><surname>Pereira da Silva</surname><given-names>S.</given-names></name>; <name><surname>Aungkulanon</surname><given-names>S.</given-names></name>; <name><surname>Buchholz</surname><given-names>U.</given-names></name>; <name><surname>Widdowson</surname><given-names>M.-A.</given-names></name>; <name><surname>Bresee</surname><given-names>J. S.</given-names></name>; <name><surname>Azziz-Baumgartner</surname><given-names>E.</given-names></name>; <name><surname>Cheng</surname><given-names>P.-Y.</given-names></name>; <name><surname>Dawood</surname><given-names>F.</given-names></name>; <name><surname>Foppa</surname><given-names>I.</given-names></name>; <name><surname>Olsen</surname><given-names>S.</given-names></name>; <name><surname>Haber</surname><given-names>M.</given-names></name>; <name><surname>Jeffers</surname><given-names>C.</given-names></name>; <name><surname>MacIntyre</surname><given-names>C. R.</given-names></name>; <name><surname>Newall</surname><given-names>A. T.</given-names></name>; <name><surname>Wood</surname><given-names>J. G.</given-names></name>; <name><surname>Kundi</surname><given-names>M.</given-names></name>; <name><surname>Popow-Kraupp</surname><given-names>T.</given-names></name>; <name><surname>Ahmed</surname><given-names>M.</given-names></name>; <name><surname>Rahman</surname><given-names>M.</given-names></name>; <name><surname>Marinho</surname><given-names>F.</given-names></name>; <name><surname>Sotomayor Proschle</surname><given-names>C. V.</given-names></name>; <name><surname>Vergara Mallegas</surname><given-names>N.</given-names></name>; <name><surname>Luzhao</surname><given-names>F.</given-names></name>; <name><surname>Sa</surname><given-names>L.</given-names></name>; <name><surname>Barbosa-Ram&#x000ed;rez</surname><given-names>J.</given-names></name>; <name><surname>Sanchez</surname><given-names>D. M.</given-names></name>; <name><surname>Gomez</surname><given-names>L. A.</given-names></name>; <name><surname>Vargas</surname><given-names>X. B.</given-names></name>; <name><surname>Acosta
Herrera</surname><given-names>a.</given-names></name>; <name><surname>Llan&#x000e9;s</surname><given-names>M. J.</given-names></name>; <name><surname>Fischer</surname><given-names>T. K.</given-names></name>; <name><surname>Krause</surname><given-names>T. G.</given-names></name>; <name><surname>M&#x000f8;lbak</surname><given-names>K.</given-names></name>; <name><surname>Nielsen</surname><given-names>J.</given-names></name>; <name><surname>Trebbien</surname><given-names>R.</given-names></name>; <name><surname>Bruno</surname><given-names>A.</given-names></name>; <name><surname>Ojeda</surname><given-names>J.</given-names></name>; <name><surname>Ramos</surname><given-names>H.</given-names></name>; <name><surname>an der Heiden</surname><given-names>M.</given-names></name>; <name><surname>del Carmen Castillo Signor</surname><given-names>L.</given-names></name>; <name><surname>Serrano</surname><given-names>C. E.</given-names></name>; <name><surname>Bhardwaj</surname><given-names>R.</given-names></name>; <name><surname>Chadha</surname><given-names>M.</given-names></name>; <name><surname>Narayan</surname><given-names>V.</given-names></name>; <name><surname>Kosen</surname><given-names>S.</given-names></name>; <name><surname>Bromberg</surname><given-names>M.</given-names></name>; <name><surname>Glatman-Freedman</surname><given-names>A.</given-names></name>; <name><surname>Kaufman</surname><given-names>Z.</given-names></name>; <name><surname>Arima</surname><given-names>Y.</given-names></name>; <name><surname>Oishi</surname><given-names>K.</given-names></name>; <name><surname>Chaves</surname><given-names>S.</given-names></name>; <name><surname>Nyawanda</surname><given-names>B.</given-names></name>; <name><surname>Al-Jarallah</surname><given-names>R. A.</given-names></name>; <name><surname>Kuri-Morales</surname><given-names>P. A.</given-names></name>; <name><surname>Matus</surname><given-names>C. R.</given-names></name>; <name><surname>Corona</surname><given-names>M. E. J.</given-names></name>; <name><surname>Burmaa</surname><given-names>A.</given-names></name>; <name><surname>Darmaa</surname><given-names>O.</given-names></name>; <name><surname>Obtel</surname><given-names>M.</given-names></name>; <name><surname>Cherkaoui</surname><given-names>I.</given-names></name>; <name><surname>van den Wijngaard</surname><given-names>C. C.</given-names></name>; <name><surname>van der Hoek</surname><given-names>W.</given-names></name>; <name><surname>Baker</surname><given-names>M.</given-names></name>; <name><surname>Bandaranayake</surname><given-names>D.</given-names></name>; <name><surname>Bissielo</surname><given-names>A.</given-names></name>; <name><surname>Huang</surname><given-names>S.</given-names></name>; <name><surname>Lopez</surname><given-names>L.</given-names></name>; <name><surname>Newbern</surname><given-names>C.</given-names></name>; <name><surname>Flem</surname><given-names>E.</given-names></name>; <name><surname>Gr&#x000f8;neng</surname><given-names>G. M.</given-names></name>; <name><surname>Hauge</surname><given-names>S.</given-names></name>; <name><surname>de Cos&#x000ed;o</surname><given-names>F. G.</given-names></name>; <name><surname>de Molt&#x000f3;</surname><given-names>Y.</given-names></name>; <name><surname>Castillo</surname><given-names>L. M.</given-names></name>; <name><surname>Cabello</surname><given-names>M. A.</given-names></name>; <name><surname>von Horoch</surname><given-names>M.</given-names></name>; <name><surname>Medina Osis</surname><given-names>J.</given-names></name>; <name><surname>Machado</surname><given-names>A.</given-names></name>; <name><surname>Nunes</surname><given-names>B.</given-names></name>; <name><surname>Rodrigues</surname><given-names>A. P.</given-names></name>; <name><surname>Rodrigues</surname><given-names>E.</given-names></name>; <name><surname>Calomfirescu</surname><given-names>C.</given-names></name>; <name><surname>Lupulescu</surname><given-names>E.</given-names></name>; <name><surname>Popescu</surname><given-names>R.</given-names></name>; <name><surname>Popovici</surname><given-names>O.</given-names></name>; <name><surname>Bogdanovic</surname><given-names>D.</given-names></name>; <name><surname>Kostic</surname><given-names>M.</given-names></name>; <name><surname>Lazarevic</surname><given-names>K.</given-names></name>; <name><surname>Milosevic</surname><given-names>Z.</given-names></name>; <name><surname>Tiodorovic</surname><given-names>B.</given-names></name>; <name><surname>Chen</surname><given-names>M.</given-names></name>; <name><surname>Cutter</surname><given-names>J.</given-names></name>; <name><surname>Lee</surname><given-names>V.</given-names></name>; <name><surname>Lin</surname><given-names>R.</given-names></name>; <name><surname>Ma</surname><given-names>S.</given-names></name>; <name><surname>Cohen</surname><given-names>A. L.</given-names></name>; <name><surname>Treurnicht</surname><given-names>F.</given-names></name>; <name><surname>Kim</surname><given-names>W. J.</given-names></name>; <name><surname>Delgado-Sanz</surname><given-names>C.</given-names></name>; <name><surname>de mateo Onta&#x000f1;&#x000f3;n</surname><given-names>S.</given-names></name>; <name><surname>Larrauri</surname><given-names>A.</given-names></name>; <name><surname>Le&#x000f3;n</surname><given-names>I. L.</given-names></name>; <name><surname>Vallejo</surname><given-names>F.</given-names></name>; <name><surname>Born</surname><given-names>R.</given-names></name>; <name><surname>Junker</surname><given-names>C.</given-names></name>; <name><surname>Koch</surname><given-names>D.</given-names></name>; <name><surname>Chuang</surname><given-names>J.-H.</given-names></name>; <name><surname>Huang</surname><given-names>W.-T.</given-names></name>; <name><surname>Kuo</surname><given-names>H.-W.</given-names></name>; <name><surname>Tsai</surname><given-names>Y.-C.</given-names></name>; <name><surname>Bundhamcharoen</surname><given-names>K.</given-names></name>; <name><surname>Chittaganpitch</surname><given-names>M.</given-names></name>; <name><surname>Green</surname><given-names>H. K.</given-names></name>; <name><surname>Pebody</surname><given-names>R.</given-names></name>; <name><surname>Go&#x000f1;i</surname><given-names>N.</given-names></name>; <name><surname>Chiparelli</surname><given-names>H.</given-names></name>; <name><surname>Brammer</surname><given-names>L.</given-names></name>; <name><surname>Mustaquim</surname><given-names>D.</given-names></name>
<article-title>Estimates
of Global Seasonal Influenza-Associated Respiratory Mortality: A Modelling
Study</article-title>. <source>Lancet</source>
<year>2018</year>, <volume>391</volume>, <fpage>1285</fpage>&#x02013;<lpage>1300</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(17)33293-2</pub-id>.<pub-id pub-id-type="pmid">29248255</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="weblink" id="cit2"><person-group person-group-type="allauthors"><collab>World Heath Organisation</collab></person-group>. <article-title>Fact Sheet&#x02014;Influenza (Seasonal)</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)">https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)</uri> (accessed March 10, 2020).</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Rogers</surname><given-names>G. N.</given-names></name>; <name><surname>D&#x02019;Souza</surname><given-names>B. L.</given-names></name>
<article-title>Receptor
Binding Properties of Human and Animal H1
Influenza Virus Isolates</article-title>. <source>Virology</source>
<year>1989</year>, <volume>173</volume>, <fpage>317</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/0042-6822(89)90249-3</pub-id>.<pub-id pub-id-type="pmid">2815586</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Connor</surname><given-names>R. J.</given-names></name>; <name><surname>Kawaoka</surname><given-names>Y.</given-names></name>; <name><surname>Webster</surname><given-names>R. G.</given-names></name>; <name><surname>Paulson</surname><given-names>J. C.</given-names></name>
<article-title>Receptor Specificity
in Human, Avian, and Equine H2 and H3 Influenza Virus Isolates</article-title>. <source>Virology</source>
<year>1994</year>, <volume>205</volume>, <fpage>17</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1006/viro.1994.1615</pub-id>.<pub-id pub-id-type="pmid">7975212</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Webster</surname><given-names>R. G.</given-names></name>; <name><surname>Laver</surname><given-names>W. G.</given-names></name>; <name><surname>Air</surname><given-names>G. M.</given-names></name>; <name><surname>Schild</surname><given-names>G. C.</given-names></name>
<article-title>Molecular Mechanisms
of Variation in Influenza Viruses</article-title>. <source>Nature</source>
<year>1982</year>, <volume>296</volume>, <fpage>115</fpage>&#x02013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1038/296115a0</pub-id>.<pub-id pub-id-type="pmid">6174870</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Gamblin</surname><given-names>S. J.</given-names></name>; <name><surname>Haire</surname><given-names>L. F.</given-names></name>; <name><surname>Russell</surname><given-names>R. J.</given-names></name>; <name><surname>Stevens</surname><given-names>D. J.</given-names></name>; <name><surname>Xiao</surname><given-names>B.</given-names></name>; <name><surname>Ha</surname><given-names>Y.</given-names></name>; <name><surname>Vasisht</surname><given-names>N.</given-names></name>; <name><surname>Steinhauer</surname><given-names>D. A.</given-names></name>; <name><surname>Daniels</surname><given-names>R. S.</given-names></name>; <name><surname>Elliot</surname><given-names>A.</given-names></name>; <name><surname>Wiley</surname><given-names>D. C.</given-names></name>; <name><surname>Skehel</surname><given-names>J. J.</given-names></name>
<article-title>The Structure and Receptor Binding
Properties of the 1918 Influenza Hemagglutinin</article-title>. <source>Science</source>
<year>2004</year>, <volume>303</volume>, <fpage>1838</fpage>&#x02013;<lpage>1842</lpage>. <pub-id pub-id-type="doi">10.1126/science.1093155</pub-id>.<pub-id pub-id-type="pmid">14764886</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Rogers</surname><given-names>G. N.</given-names></name>; <name><surname>Paulson</surname><given-names>J. C.</given-names></name>; <name><surname>Daniels</surname><given-names>R. S.</given-names></name>; <name><surname>Skehel</surname><given-names>J. J.</given-names></name>; <name><surname>Wilson</surname><given-names>I. A.</given-names></name>; <name><surname>Wiley</surname><given-names>D. C.</given-names></name>
<article-title>Single Amino Acid
Substitutions in Influenza Haemagglutinin
Change Receptor Binding Specificity</article-title>. <source>Nature</source>
<year>1983</year>, <volume>304</volume>, <fpage>76</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1038/304076a0</pub-id>.<pub-id pub-id-type="pmid">6191220</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="weblink" id="cit8"><person-group person-group-type="allauthors"><collab>World Health Organisation</collab></person-group>. <article-title>Fact Sheet&#x02014;Influenza (Avian
and other zoonotic)</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic)">https://www.who.int/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic)</uri> (accessed March 10, 2020).</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Broszeit</surname><given-names>F.</given-names></name>; <name><surname>Tzarum</surname><given-names>N.</given-names></name>; <name><surname>Zhu</surname><given-names>X.</given-names></name>; <name><surname>Nemanichvili</surname><given-names>N.</given-names></name>; <name><surname>Eggink</surname><given-names>D.</given-names></name>; <name><surname>Leenders</surname><given-names>T.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Liu</surname><given-names>L.</given-names></name>; <name><surname>Wolfert</surname><given-names>M. A.</given-names></name>; <name><surname>Papanikolaou</surname><given-names>A.</given-names></name>; <name><surname>Mart&#x000ed;nez-Romero</surname><given-names>C.</given-names></name>; <name><surname>Gagarinov</surname><given-names>I. A.</given-names></name>; <name><surname>Yu</surname><given-names>W.</given-names></name>; <name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A.</given-names></name>; <name><surname>Wennekes</surname><given-names>T.</given-names></name>; <name><surname>Okamatsu</surname><given-names>M.</given-names></name>; <name><surname>Verheije</surname><given-names>M. H.</given-names></name>; <name><surname>Wilson</surname><given-names>I. A.</given-names></name>; <name><surname>Boons</surname><given-names>G.-J.</given-names></name>; <name><surname>de Vries</surname><given-names>R. P.</given-names></name>
<article-title>N-Glycolylneuraminic Acid as a Receptor
for Influenza A Viruses</article-title>. <source>Cell Rep.</source>
<year>2019</year>, <volume>27</volume>, <fpage>3284</fpage>&#x02013;<lpage>3294.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.05.048</pub-id>.<pub-id pub-id-type="pmid">31189111</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Byrd-Leotis</surname><given-names>L.</given-names></name>; <name><surname>Jia</surname><given-names>N.</given-names></name>; <name><surname>Dutta</surname><given-names>S.</given-names></name>; <name><surname>Trost</surname><given-names>J. F.</given-names></name>; <name><surname>Gao</surname><given-names>C.</given-names></name>; <name><surname>Cummings</surname><given-names>S. F.</given-names></name>; <name><surname>Braulke</surname><given-names>T.</given-names></name>; <name><surname>M&#x000fc;ller-Loennies</surname><given-names>S.</given-names></name>; <name><surname>Heimburg-Molinaro</surname><given-names>J.</given-names></name>; <name><surname>Steinhauer</surname><given-names>D. A.</given-names></name>; <name><surname>Cummings</surname><given-names>R. D.</given-names></name>
<article-title>Influenza Binds Phosphorylated Glycans
from Human Lung</article-title>. <source>Sci. Adv.</source>
<year>2019</year>, <volume>5</volume>, <elocation-id>eaav2554</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aav2554</pub-id>.<pub-id pub-id-type="pmid">30788437</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Gulati</surname><given-names>S.</given-names></name>; <name><surname>Lasanajak</surname><given-names>Y.</given-names></name>; <name><surname>Smith</surname><given-names>D. F.</given-names></name>; <name><surname>Cummings</surname><given-names>R. D.</given-names></name>; <name><surname>Air</surname><given-names>G. M.</given-names></name>
<article-title>Glycan
Array Analysis of Influenza H1N1 Binding and Release</article-title>. <source>Cancer Biomarkers</source>
<year>2014</year>, <volume>14</volume>, <fpage>43</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.3233/cbm-130376</pub-id>.<pub-id pub-id-type="pmid">24643041</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Sauter</surname><given-names>N. K.</given-names></name>; <name><surname>Bednarski</surname><given-names>M. D.</given-names></name>; <name><surname>Wurzburg</surname><given-names>B. A.</given-names></name>; <name><surname>Hanson</surname><given-names>J. E.</given-names></name>; <name><surname>Whitesides</surname><given-names>G. M.</given-names></name>; <name><surname>Skehel</surname><given-names>J. J.</given-names></name>; <name><surname>Wiley</surname><given-names>D. C.</given-names></name>
<article-title>Hemagglutinins from Two Influenza
Virus Variants Bind to Sialic Acid Derivatives with Millimolar Dissociation
Constants: A 500-MHz Proton Nuclear Magnetic Resonance Study</article-title>. <source>Biochemistry</source>
<year>1989</year>, <volume>28</volume>, <fpage>8388</fpage>&#x02013;<lpage>8396</lpage>. <pub-id pub-id-type="doi">10.1021/bi00447a018</pub-id>.<pub-id pub-id-type="pmid">2605190</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Weis</surname><given-names>W.</given-names></name>; <name><surname>Brown</surname><given-names>J. H.</given-names></name>; <name><surname>Cusack</surname><given-names>S.</given-names></name>; <name><surname>Paulson</surname><given-names>J. C.</given-names></name>; <name><surname>Skehel</surname><given-names>J. J.</given-names></name>; <name><surname>Wiley</surname><given-names>D. C.</given-names></name>
<article-title>Structure of the
Influenza Virus Haemagglutinin Complexed
with Its Receptor, Sialic Acid</article-title>. <source>Nature</source>
<year>1988</year>, <volume>333</volume>, <fpage>426</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1038/333426a0</pub-id>.<pub-id pub-id-type="pmid">3374584</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Lundquist</surname><given-names>J. J.</given-names></name>; <name><surname>Toone</surname><given-names>E. J.</given-names></name>
<article-title>The Cluster Glycoside Effect</article-title>. <source>Chem. Rev.</source>
<year>2002</year>, <volume>102</volume>, <fpage>555</fpage>&#x02013;<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1021/cr000418f</pub-id>.<pub-id pub-id-type="pmid">11841254</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Gou</surname><given-names>Y.</given-names></name>; <name><surname>Richards</surname><given-names>S.-J.</given-names></name>; <name><surname>Haddleton</surname><given-names>D. M.</given-names></name>; <name><surname>Gibson</surname><given-names>M. I.</given-names></name>
<article-title>Investigation of
Glycopolymer-Lectin Interactions Using QCM-d: Comparison of Surface
Binding with Inhibitory Activity</article-title>. <source>Polym. Chem.</source>
<year>2012</year>, <volume>3</volume>, <fpage>1634</fpage>&#x02013;<lpage>1640</lpage>. <pub-id pub-id-type="doi">10.1039/c2py20140b</pub-id>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Gou</surname><given-names>Y.</given-names></name>; <name><surname>Geng</surname><given-names>J.</given-names></name>; <name><surname>Richards</surname><given-names>S.-J.</given-names></name>; <name><surname>Burns</surname><given-names>J.</given-names></name>; <name><surname>Remzi Becer</surname><given-names>C.</given-names></name>; <name><surname>Haddleton</surname><given-names>D. M.</given-names></name>
<article-title>A Detailed Study on Understanding Glycopolymer Library
and Con A Interactions</article-title>. <source>J. Polym. Sci., Part
A: Polym. Chem.</source>
<year>2013</year>, <volume>51</volume>, <fpage>2588</fpage>&#x02013;<lpage>2597</lpage>. <pub-id pub-id-type="doi">10.1002/pola.26646</pub-id>.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>G.</given-names></name>; <name><surname>Stenzel</surname><given-names>M. H.</given-names></name>
<article-title>Synthesis
and Lectin Recognition
of Glyco Star Polymers Prepared by &#x0201c;Clicking&#x0201d; Thiocarbohydrates
onto a Reactive Scaffold</article-title>. <source>Macromolecules</source>
<year>2010</year>, <volume>43</volume>, <fpage>8109</fpage>&#x02013;<lpage>8114</lpage>. <pub-id pub-id-type="doi">10.1021/ma100919x</pub-id>.</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Ponader</surname><given-names>D.</given-names></name>; <name><surname>Wojcik</surname><given-names>F.</given-names></name>; <name><surname>Beceren-Braun</surname><given-names>F.</given-names></name>; <name><surname>Dernedde</surname><given-names>J.</given-names></name>; <name><surname>Hartmann</surname><given-names>L.</given-names></name>
<article-title>Sequence-Defined
Glycopolymer Segments Presenting Mannose: Synthesis and Lectin Binding
Affinity</article-title>. <source>Biomacromolecules</source>
<year>2012</year>, <volume>13</volume>, <fpage>1845</fpage>&#x02013;<lpage>1852</lpage>. <pub-id pub-id-type="doi">10.1021/bm300331z</pub-id>.<pub-id pub-id-type="pmid">22483345</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Baradel</surname><given-names>N.</given-names></name>; <name><surname>Fort</surname><given-names>S.</given-names></name>; <name><surname>Halila</surname><given-names>S.</given-names></name>; <name><surname>Badi</surname><given-names>N.</given-names></name>; <name><surname>Lutz</surname><given-names>J.-F.</given-names></name>
<article-title>Synthesis
of Single-Chain Sugar Arrays</article-title>. <source>Angew. Chem.,
Int. Ed.</source>
<year>2013</year>, <volume>52</volume>, <fpage>2335</fpage>&#x02013;<lpage>2339</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201209052</pub-id>.</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Mammen</surname><given-names>M.</given-names></name>; <name><surname>Dahmann</surname><given-names>G.</given-names></name>; <name><surname>Whitesides</surname><given-names>G. M.</given-names></name>
<article-title>Effective
Inhibitors of Hemagglutination
by Influenza Virus Synthesized from Polymers Having Active Ester Groups.
Insight into Mechanism of Inhibition</article-title>. <source>J. Med.
Chem.</source>
<year>1995</year>, <volume>38</volume>, <fpage>4179</fpage>&#x02013;<lpage>4190</lpage>. <pub-id pub-id-type="doi">10.1021/jm00021a007</pub-id>.<pub-id pub-id-type="pmid">7473545</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Sigal</surname><given-names>G. B.</given-names></name>; <name><surname>Mammen</surname><given-names>M.</given-names></name>; <name><surname>Dahmann</surname><given-names>G.</given-names></name>; <name><surname>Whitesides</surname><given-names>G. M.</given-names></name>
<article-title>Polyacrylamides
Bearing Pendant &#x003b1;-Sialoside Groups Strongly Inhibit Agglutination
of Erythrocytes by Influenza Virus: The Strong Inhibition Reflects
Enhanced Binding through Cooperative Polyvalent Interactions</article-title>. <source>J. Am. Chem. Soc.</source>
<year>1996</year>, <volume>118</volume>, <fpage>3789</fpage>&#x02013;<lpage>3800</lpage>. <pub-id pub-id-type="doi">10.1021/ja953729u</pub-id>.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Nagao</surname><given-names>M.</given-names></name>; <name><surname>Fujiwara</surname><given-names>Y.</given-names></name>; <name><surname>Matsubara</surname><given-names>T.</given-names></name>; <name><surname>Hoshino</surname><given-names>Y.</given-names></name>; <name><surname>Sato</surname><given-names>T.</given-names></name>; <name><surname>Miura</surname><given-names>Y.</given-names></name>
<article-title>Design of Glycopolymers
Carrying Sialyl Oligosaccharides for Controlling
the Interaction with the Influenza Virus</article-title>. <source>Biomacromolecules</source>
<year>2017</year>, <volume>18</volume>, <fpage>4385</fpage>&#x02013;<lpage>4392</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biomac.7b01426</pub-id>.<pub-id pub-id-type="pmid">29111681</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Lu</surname><given-names>W.</given-names></name>; <name><surname>Du</surname><given-names>W.</given-names></name>; <name><surname>Somovilla</surname><given-names>V. J.</given-names></name>; <name><surname>Yu</surname><given-names>G.</given-names></name>; <name><surname>Haksar</surname><given-names>D.</given-names></name>; <name><surname>de Vries</surname><given-names>E.</given-names></name>; <name><surname>Boons</surname><given-names>G.-J.</given-names></name>; <name><surname>de Vries</surname><given-names>R. P.</given-names></name>; <name><surname>de Haan</surname><given-names>C. A. M.</given-names></name>; <name><surname>Pieters</surname><given-names>R. J.</given-names></name>
<article-title>Enhanced
Inhibition of Influenza A Virus Adhesion by Di- and Trivalent Hemagglutinin
Inhibitors</article-title>. <source>J. Med. Chem.</source>
<year>2019</year>, <volume>62</volume>, <fpage>6398</fpage>&#x02013;<lpage>6404</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.9b00303</pub-id>.<pub-id pub-id-type="pmid">31251606</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Huang</surname><given-names>M. L.</given-names></name>; <name><surname>Cohen</surname><given-names>M.</given-names></name>; <name><surname>Fisher</surname><given-names>C. J.</given-names></name>; <name><surname>Schooley</surname><given-names>R. T.</given-names></name>; <name><surname>Gagneux</surname><given-names>P.</given-names></name>; <name><surname>Godula</surname><given-names>K.</given-names></name>
<article-title>Determination of Receptor Specificities
for Whole Influenza
Viruses Using Multivalent Glycan Arrays</article-title>. <source>Chem.
Commun.</source>
<year>2015</year>, <volume>51</volume>, <fpage>5326</fpage>&#x02013;<lpage>5329</lpage>. <pub-id pub-id-type="doi">10.1039/c4cc08613a</pub-id>.</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Bandlow</surname><given-names>V.</given-names></name>; <name><surname>Liese</surname><given-names>S.</given-names></name>; <name><surname>Lauster</surname><given-names>D.</given-names></name>; <name><surname>Ludwig</surname><given-names>K.</given-names></name>; <name><surname>Netz</surname><given-names>R. R.</given-names></name>; <name><surname>Herrmann</surname><given-names>A.</given-names></name>; <name><surname>Seitz</surname><given-names>O.</given-names></name>
<article-title>Spatial Screening
of Hemagglutinin
on Influenza A Virus Particles: Sialyl-LacNAc Displays on DNA and
PEG Scaffolds Reveal the Requirements for Bivalency Enhanced Interactions
with Weak Monovalent Binders</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2017</year>, <volume>139</volume>, <fpage>16389</fpage>&#x02013;<lpage>16397</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.7b09967</pub-id>.<pub-id pub-id-type="pmid">29052990</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Peng</surname><given-names>W.</given-names></name>; <name><surname>de Vries</surname><given-names>R. P.</given-names></name>; <name><surname>Grant</surname><given-names>O. C.</given-names></name>; <name><surname>Thompson</surname><given-names>A. J.</given-names></name>; <name><surname>McBride</surname><given-names>R.</given-names></name>; <name><surname>Tsogtbaatar</surname><given-names>B.</given-names></name>; <name><surname>Lee</surname><given-names>P. S.</given-names></name>; <name><surname>Razi</surname><given-names>N.</given-names></name>; <name><surname>Wilson</surname><given-names>I. A.</given-names></name>; <name><surname>Woods</surname><given-names>R. J.</given-names></name>; <name><surname>Paulson</surname><given-names>J. C.</given-names></name>
<article-title>Recent H3N2 Viruses
Have Evolved
Specificity for Extended, Branched Human-Type Receptors, Conferring
Potential for Increased Avidity</article-title>. <source>Cell Host Microbe</source>
<year>2017</year>, <volume>21</volume>, <fpage>23</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2016.11.004</pub-id>.<pub-id pub-id-type="pmid">28017661</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Bhatia</surname><given-names>S.</given-names></name>; <name><surname>Lauster</surname><given-names>D.</given-names></name>; <name><surname>Bardua</surname><given-names>M.</given-names></name>; <name><surname>Ludwig</surname><given-names>K.</given-names></name>; <name><surname>Angioletti-Uberti</surname><given-names>S.</given-names></name>; <name><surname>Popp</surname><given-names>N.</given-names></name>; <name><surname>Hoffmann</surname><given-names>U.</given-names></name>; <name><surname>Paulus</surname><given-names>F.</given-names></name>; <name><surname>Budt</surname><given-names>M.</given-names></name>; <name><surname>Stadtm&#x000fc;ller</surname><given-names>M.</given-names></name>; <name><surname>Wolff</surname><given-names>T.</given-names></name>; <name><surname>Hamann</surname><given-names>A.</given-names></name>; <name><surname>B&#x000f6;ttcher</surname><given-names>C.</given-names></name>; <name><surname>Herrmann</surname><given-names>A.</given-names></name>; <name><surname>Haag</surname><given-names>R.</given-names></name>
<article-title>Linear Polysialoside Outperforms
Dendritic Analogs for Inhibition of Influenza Virus Infection in Vitro
and in Vivo</article-title>. <source>Biomaterials</source>
<year>2017</year>, <volume>138</volume>, <fpage>22</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.05.028</pub-id>.<pub-id pub-id-type="pmid">28550754</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Richards</surname><given-names>S.-J.</given-names></name>; <name><surname>Gibson</surname><given-names>M. I.</given-names></name>
<article-title>Optimization of
the Polymer Coating for Glycosylated
Gold Nanoparticle Biosensors to Ensure Stability and Rapid Optical
Readouts</article-title>. <source>ACS Macro Lett.</source>
<year>2014</year>, <volume>3</volume>, <fpage>1004</fpage>&#x02013;<lpage>1008</lpage>. <pub-id pub-id-type="doi">10.1021/mz5004882</pub-id>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Richards</surname><given-names>S.-J.</given-names></name>; <name><surname>Otten</surname><given-names>L.</given-names></name>; <name><surname>Gibson</surname><given-names>M. I.</given-names></name>; <name><surname>Besra</surname><given-names>G. S.</given-names></name>; <name><surname>Gibson</surname><given-names>M. I.</given-names></name>
<article-title>Glycosylated
Gold Nanoparticle Libraries for Label-Free Multiplexed Lectin Biosensing</article-title>. <source>J. Mater. Chem. B</source>
<year>2016</year>, <volume>4</volume>, <fpage>3046</fpage>&#x02013;<lpage>3053</lpage>. <pub-id pub-id-type="doi">10.1039/c5tb01994j</pub-id>.<pub-id pub-id-type="pmid">27162639</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="book" id="cit30"><person-group person-group-type="allauthors"><name><surname>Richards</surname><given-names>S.-J.</given-names></name>; <name><surname>Biggs</surname><given-names>C. I.</given-names></name>; <name><surname>Gibson</surname><given-names>M. I.</given-names></name></person-group><article-title>Multivalent
Glycopolymer-Coated Gold Nanoparticles</article-title>. <source>Macro-Glycoligands</source>; <series>Methods in Molecular Biology</series>; <publisher-name>Springer</publisher-name>, <year>2016</year>; Vol. <volume>1367</volume>, pp <fpage>169</fpage>&#x02013;<lpage>179</lpage>.</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Otten</surname><given-names>L.</given-names></name>; <name><surname>Vlachou</surname><given-names>D.</given-names></name>; <name><surname>Richards</surname><given-names>S.-J.</given-names></name>; <name><surname>Gibson</surname><given-names>M. I.</given-names></name>
<article-title>Glycan Heterogeneity
on Gold Nanoparticles Increases Lectin Discrimination Capacity in
Label-Free Multiplexed Bioassays</article-title>. <source>Analyst</source>
<year>2016</year>, <volume>141</volume>, <fpage>4305</fpage>&#x02013;<lpage>4312</lpage>. <pub-id pub-id-type="doi">10.1039/c6an00549g</pub-id>.<pub-id pub-id-type="pmid">27181289</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Mar&#x000ed;n</surname><given-names>M. J.</given-names></name>; <name><surname>Rashid</surname><given-names>A.</given-names></name>; <name><surname>Rejzek</surname><given-names>M.</given-names></name>; <name><surname>Fairhurst</surname><given-names>S. A.</given-names></name>; <name><surname>Wharton</surname><given-names>S. A.</given-names></name>; <name><surname>Martin</surname><given-names>S. R.</given-names></name>; <name><surname>McCauley</surname><given-names>J. W.</given-names></name>; <name><surname>Wileman</surname><given-names>T.</given-names></name>; <name><surname>Field</surname><given-names>R. A.</given-names></name>; <name><surname>Russell</surname><given-names>D. A.</given-names></name>
<article-title>Glyconanoparticles for the Plasmonic
Detection and Discrimination between Human and Avian Influenza Virus</article-title>. <source>Org. Biomol. Chem.</source>
<year>2013</year>, <volume>11</volume>, <fpage>7101</fpage><pub-id pub-id-type="doi">10.1039/c3ob41703d</pub-id>.<pub-id pub-id-type="pmid">24057694</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Poonthiyil</surname><given-names>V.</given-names></name>; <name><surname>Nagesh</surname><given-names>P. T.</given-names></name>; <name><surname>Husain</surname><given-names>M.</given-names></name>; <name><surname>Golovko</surname><given-names>V. B.</given-names></name>; <name><surname>Fairbanks</surname><given-names>A. J.</given-names></name>
<article-title>Gold Nanoparticles
Decorated with Sialic Acid Terminated Bi-Antennary N-Glycans for the
Detection of Influenza Virus at Nanomolar Concentrations</article-title>. <source>ChemistryOpen</source>
<year>2015</year>, <volume>4</volume>, <fpage>708</fpage>&#x02013;<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1002/open.201500109</pub-id>.<pub-id pub-id-type="pmid">27308196</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Zhang</surname><given-names>Z.</given-names></name>; <name><surname>Schepens</surname><given-names>B.</given-names></name>; <name><surname>Nuhn</surname><given-names>L.</given-names></name>; <name><surname>Saelens</surname><given-names>X.</given-names></name>; <name><surname>Schotsaert</surname><given-names>M.</given-names></name>; <name><surname>Callewaert</surname><given-names>N.</given-names></name>; <name><surname>De Rycke</surname><given-names>R.</given-names></name>; <name><surname>Zhang</surname><given-names>Q.</given-names></name>; <name><surname>Moins</surname><given-names>S.</given-names></name>; <name><surname>Benali</surname><given-names>S.</given-names></name>; <name><surname>Mespouille</surname><given-names>L.</given-names></name>; <name><surname>Hoogenboom</surname><given-names>R.</given-names></name>; <name><surname>De Geest</surname><given-names>B. G.</given-names></name>
<article-title>Influenza-Binding
Sialylated Polymer Coated Gold Nanoparticles
Prepared via RAFT Polymerization and Reductive Amination</article-title>. <source>Chem. Commun.</source>
<year>2016</year>, <volume>52</volume>, <fpage>3352</fpage>&#x02013;<lpage>3355</lpage>. <pub-id pub-id-type="doi">10.1039/c6cc00501b</pub-id>.</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Papp</surname><given-names>I.</given-names></name>; <name><surname>Sieben</surname><given-names>C.</given-names></name>; <name><surname>Ludwig</surname><given-names>K.</given-names></name>; <name><surname>Roskamp</surname><given-names>M.</given-names></name>; <name><surname>B&#x000f6;ttcher</surname><given-names>C.</given-names></name>; <name><surname>Schlecht</surname><given-names>S.</given-names></name>; <name><surname>Herrmann</surname><given-names>A.</given-names></name>; <name><surname>Haag</surname><given-names>R.</given-names></name>
<article-title>Inhibition of Influenza
Virus Infection by Multivalent Sialic-Acid- Functionalized Gold Nanoparticles</article-title>. <source>Small</source>
<year>2010</year>, <volume>6</volume>, <fpage>2900</fpage>&#x02013;<lpage>2906</lpage>. <pub-id pub-id-type="doi">10.1002/smll.201001349</pub-id>.<pub-id pub-id-type="pmid">21104827</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Richards</surname><given-names>S.-J.</given-names></name>; <name><surname>Fullam</surname><given-names>E.</given-names></name>; <name><surname>Besra</surname><given-names>G. S.</given-names></name>; <name><surname>Gibson</surname><given-names>M. I.</given-names></name>
<article-title>Discrimination between
Bacterial Phenotypes Using Glyco-Nanoparticles and the Impact of Polymer
Coating on Detection Readouts</article-title>. <source>J. Mater. Chem.
B</source>
<year>2014</year>, <volume>2</volume>, <fpage>1490</fpage>&#x02013;<lpage>1498</lpage>. <pub-id pub-id-type="doi">10.1039/c3tb21821j</pub-id>.<pub-id pub-id-type="pmid">32261368</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Di
Iorio</surname><given-names>D.</given-names></name>; <name><surname>Verheijden</surname><given-names>M. L.</given-names></name>; <name><surname>Van Der Vries</surname><given-names>E.</given-names></name>; <name><surname>Jonkheijm</surname><given-names>P.</given-names></name>; <name><surname>Huskens</surname><given-names>J.</given-names></name>
<article-title>Weak Multivalent Binding of Influenza
Hemagglutinin Nanoparticles at a Sialoglycan-Functionalized Supported
Lipid Bilayer</article-title>. <source>ACS Nano</source>
<year>2019</year>, <volume>13</volume>, <fpage>3413</fpage>&#x02013;<lpage>3423</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.8b09410</pub-id>.<pub-id pub-id-type="pmid">30844236</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Kwon</surname><given-names>S.-J.</given-names></name>; <name><surname>Na</surname><given-names>D. H.</given-names></name>; <name><surname>Kwak</surname><given-names>J. H.</given-names></name>; <name><surname>Douaisi</surname><given-names>M.</given-names></name>; <name><surname>Zhang</surname><given-names>F.</given-names></name>; <name><surname>Park</surname><given-names>E. J.</given-names></name>; <name><surname>Park</surname><given-names>J.-H.</given-names></name>; <name><surname>Youn</surname><given-names>H.</given-names></name>; <name><surname>Song</surname><given-names>C.-S.</given-names></name>; <name><surname>Kane</surname><given-names>R. S.</given-names></name>; <name><surname>Dordick</surname><given-names>J. S.</given-names></name>; <name><surname>Lee</surname><given-names>K. B.</given-names></name>; <name><surname>Linhardt</surname><given-names>R. J.</given-names></name>
<article-title>Nanostructured
Glycan Architecture Is Important in the Inhibition of Influenza A
Virus Infection</article-title>. <source>Nat. Nanotechnol.</source>
<year>2017</year>, <volume>12</volume>, <fpage>48</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1038/nnano.2016.181</pub-id>.<pub-id pub-id-type="pmid">27775724</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Bast&#x000fa;s</surname><given-names>N. G.</given-names></name>; <name><surname>Comenge</surname><given-names>J.</given-names></name>; <name><surname>Puntes</surname><given-names>V.</given-names></name>
<article-title>Kinetically Controlled Seeded Growth
Synthesis of Citrate-Stabilized Gold Nanoparticles of up to 200 Nm:
Size Focusing versus Ostwald Ripening</article-title>. <source>Langmuir</source>
<year>2011</year>, <volume>27</volume>, <fpage>11098</fpage>&#x02013;<lpage>11105</lpage>. <pub-id pub-id-type="doi">10.1021/la201938u</pub-id>.<pub-id pub-id-type="pmid">21728302</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Richards</surname><given-names>S.-J.</given-names></name>; <name><surname>Otten</surname><given-names>L.</given-names></name>; <name><surname>Gibson</surname><given-names>M. I.</given-names></name>
<article-title>Glycosylated Gold Nanoparticle Libraries
for Label-Free Multiplexed Lectin Biosensing</article-title>. <source>J. Mater. Chem. B</source>
<year>2016</year>, <volume>4</volume>, <fpage>3046</fpage>&#x02013;<lpage>3053</lpage>. <pub-id pub-id-type="doi">10.1039/c5tb01994j</pub-id>.<pub-id pub-id-type="pmid">27162639</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Haiss</surname><given-names>W.</given-names></name>; <name><surname>Thanh</surname><given-names>N. T. K.</given-names></name>; <name><surname>Aveyard</surname><given-names>J.</given-names></name>; <name><surname>Fernig</surname><given-names>D. G.</given-names></name>
<article-title>Determination of
Size and Concentration of Gold Nanoparticles from UV&#x02013;Vis Spectra</article-title>. <source>Anal. Chem.</source>
<year>2007</year>, <volume>79</volume>, <fpage>4215</fpage>&#x02013;<lpage>4221</lpage>. <pub-id pub-id-type="doi">10.1021/ac0702084</pub-id>.<pub-id pub-id-type="pmid">17458937</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Won</surname><given-names>S.</given-names></name>; <name><surname>Richards</surname><given-names>S.-J.</given-names></name>; <name><surname>Walker</surname><given-names>M.</given-names></name>; <name><surname>Gibson</surname><given-names>M. I.</given-names></name>
<article-title>Externally Controllable
Glycan Presentation on Nanoparticle Surfaces to Modulate Lectin Recognition</article-title>. <source>Nanoscale Horiz.</source>
<year>2017</year>, <volume>2</volume>, <fpage>106</fpage>&#x02013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1039/c6nh00202a</pub-id>.<pub-id pub-id-type="pmid">28989796</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Petersen</surname><given-names>R. L.</given-names></name>
<article-title>Strategies
Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research
and Development</article-title>. <source>Biosensors</source>
<year>2017</year>, <volume>7</volume>, <fpage>49</fpage><pub-id pub-id-type="doi">10.3390/bios7040049</pub-id>.</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Dam</surname><given-names>T. K.</given-names></name>; <name><surname>Gerken</surname><given-names>T. A.</given-names></name>; <name><surname>Brewer</surname><given-names>C. F.</given-names></name>
<article-title>Thermodynamics
of Multivalent Carbohydrate-Lectin
Cross-Linking Interactions: Importance of Entropy in the Bind and
Jump Mechanism</article-title>. <source>Biochemistry</source>
<year>2009</year>, <volume>48</volume>, <fpage>3822</fpage>&#x02013;<lpage>3827</lpage>. <pub-id pub-id-type="doi">10.1021/bi9002919</pub-id>.<pub-id pub-id-type="pmid">19292456</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Dam</surname><given-names>T. K.</given-names></name>; <name><surname>Gerken</surname><given-names>T. A.</given-names></name>; <name><surname>Cavada</surname><given-names>B. S.</given-names></name>; <name><surname>Nascimento</surname><given-names>K. S.</given-names></name>; <name><surname>Moura</surname><given-names>T. R.</given-names></name>; <name><surname>Brewer</surname><given-names>C. F.</given-names></name>
<article-title>Binding Studies of Alpha-GalNAc-Specific
Lectins to the Alpha-GalNAc (Tn-Antigen) Form of Porcine Submaxillary
Mucin and Its Smaller Fragments</article-title>. <source>J. Biol. Chem.</source>
<year>2007</year>, <volume>282</volume>, <fpage>28256</fpage>&#x02013;<lpage>28263</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m704677200</pub-id>.<pub-id pub-id-type="pmid">17652089</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Godula</surname><given-names>K.</given-names></name>; <name><surname>Bertozzi</surname><given-names>C. R.</given-names></name>
<article-title>Density Variant Glycan Microarray
for Evaluating Cross-Linking
of Mucin-like Glycoconjugates by Lectins</article-title>. <source>J.
Am. Chem. Soc.</source>
<year>2012</year>, <volume>134</volume>, <fpage>15732</fpage>&#x02013;<lpage>15742</lpage>. <pub-id pub-id-type="doi">10.1021/ja302193u</pub-id>.<pub-id pub-id-type="pmid">22967056</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="book" id="cit47"><person-group person-group-type="allauthors"><name><surname>Hermanson</surname><given-names>G. T.</given-names></name></person-group><article-title>Functional
Targets</article-title>. <source>Bioconjugate Techniques</source>, <edition>3</edition>rd ed.; <publisher-name>Academic Press</publisher-name>: <publisher-loc>London</publisher-loc>, <year>2013</year>; Chapter
1.</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Peters</surname><given-names>B. P.</given-names></name>; <name><surname>Ebisu</surname><given-names>S.</given-names></name>; <name><surname>Goldstein</surname><given-names>I. J.</given-names></name>; <name><surname>Flashner</surname><given-names>M.</given-names></name>
<article-title>Interaction of Wheat
Germ Agglutinin with Sialic Acid</article-title>. <source>Biochemistry</source>
<year>1979</year>, <volume>18</volume>, <fpage>5505</fpage>&#x02013;<lpage>5511</lpage>. <pub-id pub-id-type="doi">10.1021/bi00591a038</pub-id>.<pub-id pub-id-type="pmid">92996</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Benton</surname><given-names>D. J.</given-names></name>; <name><surname>Martin</surname><given-names>S. R.</given-names></name>; <name><surname>Wharton</surname><given-names>S. A.</given-names></name>; <name><surname>McCauley</surname><given-names>J. W.</given-names></name>
<article-title>Biophysical
Measurement
of the Balance of Influenza A Hemagglutinin and Neuraminidase Activities</article-title>. <source>J. Biol. Chem.</source>
<year>2015</year>, <volume>290</volume>, <fpage>6516</fpage>&#x02013;<lpage>6521</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m114.622308</pub-id>.<pub-id pub-id-type="pmid">25586179</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Peacock</surname><given-names>T. P.</given-names></name>; <name><surname>Benton</surname><given-names>D. J.</given-names></name>; <name><surname>Sadeyen</surname><given-names>J. R.</given-names></name>; <name><surname>Chang</surname><given-names>P.</given-names></name>; <name><surname>Sealy</surname><given-names>J. E.</given-names></name>; <name><surname>Bryant</surname><given-names>J. E.</given-names></name>; <name><surname>Martin</surname><given-names>S. R.</given-names></name>; <name><surname>Shelton</surname><given-names>H.</given-names></name>; <name><surname>McCauley</surname><given-names>J. W.</given-names></name>; <name><surname>Barclay</surname><given-names>W. S.</given-names></name>; <name><surname>Iqbal</surname><given-names>M.</given-names></name>
<article-title>Variability in H9N2 Haemagglutinin
Receptor-Binding Preference and the PH of Fusion</article-title>. <source>Emerging Microbes Infect.</source>
<year>2017</year>, <volume>6</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/emi.2016.139</pub-id>.</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Du</surname><given-names>W.</given-names></name>; <name><surname>Guo</surname><given-names>H.</given-names></name>; <name><surname>Nijman</surname><given-names>V. S.</given-names></name>; <name><surname>Doedt</surname><given-names>J.</given-names></name>; <name><surname>van der Vries</surname><given-names>E.</given-names></name>; <name><surname>van der Lee</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Boons</surname><given-names>G.-J.</given-names></name>; <name><surname>van Kuppeveld</surname><given-names>F. J. M.</given-names></name>; <name><surname>de Vries</surname><given-names>E.</given-names></name>; <name><surname>Matrosovich</surname><given-names>M.</given-names></name>; <name><surname>de Haan</surname><given-names>C. A. M.</given-names></name>
<article-title>The 2nd Sialic
Acid-Binding Site of Influenza A Virus Neuraminidase Is an Important
Determinant of the Hemagglutinin-Neuraminidase-Receptor Balance</article-title>. <source>PLoS Pathog.</source>
<year>2019</year>, <volume>15</volume>, <elocation-id>e1007860</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007860</pub-id>.<pub-id pub-id-type="pmid">31181126</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Vachieri</surname><given-names>S. G.</given-names></name>; <name><surname>Xiong</surname><given-names>X.</given-names></name>; <name><surname>Collins</surname><given-names>P. J.</given-names></name>; <name><surname>Walker</surname><given-names>P. A.</given-names></name>; <name><surname>Martin</surname><given-names>S. R.</given-names></name>; <name><surname>Haire</surname><given-names>L. F.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>McCauley</surname><given-names>J. W.</given-names></name>; <name><surname>Gamblin</surname><given-names>S. J.</given-names></name>; <name><surname>Skehel</surname><given-names>J. J.</given-names></name>
<article-title>Receptor Binding by H10 Influenza Viruses</article-title>. <source>Nature</source>
<year>2014</year>, <volume>511</volume>, <fpage>475</fpage>&#x02013;<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1038/nature13443</pub-id>.<pub-id pub-id-type="pmid">24870229</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Xiong</surname><given-names>X.</given-names></name>; <name><surname>Martin</surname><given-names>S. R.</given-names></name>; <name><surname>Haire</surname><given-names>L. F.</given-names></name>; <name><surname>Wharton</surname><given-names>S. A.</given-names></name>; <name><surname>Daniels</surname><given-names>R. S.</given-names></name>; <name><surname>Bennett</surname><given-names>M. S.</given-names></name>; <name><surname>McCauley</surname><given-names>J. W.</given-names></name>; <name><surname>Collins</surname><given-names>P. J.</given-names></name>; <name><surname>Walker</surname><given-names>P. A.</given-names></name>; <name><surname>Skehel</surname><given-names>J. J.</given-names></name>; <name><surname>Gamblin</surname><given-names>S. J.</given-names></name>
<article-title>Receptor
Binding by an H7N9 Influenza
Virus from Humans</article-title>. <source>Nature</source>
<year>2013</year>, <volume>499</volume>, <fpage>496</fpage>&#x02013;<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1038/nature12372</pub-id>.<pub-id pub-id-type="pmid">23787694</pub-id></mixed-citation></ref></ref-list></back></article>